Find Funding Opportunities

Request Information RFI): Guidance Current Education Curricula Health Care Professionals Regarding Pain Opioid Misuse Use Disorder Notice Number: NOT-DA-19-054 Key Dates Release Date: July 05, 2019 Response Date: September 01, 2019 Related Announcements None Issued National Institute Drug Abuse NIDA)National Institute Aging NIA) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Dental Craniofacial Research NIDCR) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Center Complementary Integrative Health NCCIH)National Institute Biomedical Imaging Bioengineering NIBIB) Purpose RFI seeks input stakeholders throughout scientific research medical education community the general public regarding CoEPEs program, general pain education, opioid misuse use disorder education curriculum. Stakeholders interest include are limited to: health care professionals providing pain treatment, students medical, dental nursing schools, residents, fellows, teaching faculty, medical dental associations, education accrediting agencies. Background Chronic pain affects 100 million American adults costs nation to 635 billion year medical treatment lost productivity. response this public health concern the 2011 Institute Medicine report Relieving Pain America,” Department Health Human Services DHHS) created National Pain Strategy NPS). Among priorities recommendations outlined the NPS, plan identified need educate health care professionals pain, pain treatment, its interaction opioid misuse use disorder. Specifically, NPS recommended steps improve discipline-specific core competencies, including basic knowledge, assessment, effective team-based care, empathy, cultural competency. plan encouraged educational program accreditation bodies professional licensure boards require pain teaching clinician learning the undergraduate, graduate, residency continuous education levels. NPS also endorsed development a web-based pain education portal would contain up-to-date, comprehensive, easily accessed educational materials. training efforts should made coordination current DHHS efforts develop tools providers recognize risk factors symptoms opioid disorders. National Institute Health NIH) Pain Consortium established enhance pain research promote collaboration among researchers across many NIH Institutes Centers have programs activities addressing pain. line the education recommendations outlined the NPS, Pain Consortium created supports Centers Excellence Pain Education CoEPEs; https://painconsortium.nih.gov/Funding_Research/CoEPEs). CoEPEs act hubs the development, evaluation, distribution pain management curriculum resources medical, dental, nursing, pharmacy other schools enhance improve health care professionals taught pain its treatment. modules intended educate health care professionals the different types pain resulting various forms surgery, pain conditions, comorbidities, acute chronic pain treatment, opioid disorder. Information Requested RFI seeks input stakeholders throughout scientific research medical education community the general public regarding CoEPEs program, general pain, opioid misuse opioid disorder education curriculum. Stakeholders interest include are limited to: health care professionals providing pain treatment, students medical, dental, pharmacy, physical therapy nursing schools, residents, fellows, teaching faculty, medical associations, physical therapy occupational therapy associations education accrediting agencies. NIH seeks information response any all the following topics interest: nature your institution’s current curriculum pain conditions, pain treatment, opioid misuse/use disorder, overdose. Include details topics covered these categories, this training content delivered, intended audience, general goals, the particular Learning Management System LMS; e.g., Moodle), any, your institution uses manage any related training content. Information the highest priority needs training resources infrastructure needs related pain conditions, pain treatment, opioid misuse/use disorder, overdose. Topics training resources needs include are limited to: multidisciplinary approach pain assessment/management and/or empathy cultural competency content related pain conditions, pain treatment, opioid misuses/use disorder. Input the current CoEPEs education content, including whether modules being using your institution, whether fit curricular needs your institution, recommended content future development, suggestions the format e.g., explicit didactic goals, video duration, etc), any comments may enhance accessibility utilization these CoEPEs modules. Comments the importance endorsement educational program accreditation bodies professional licensure incorporate training pain OUD CoEPEs utilization your institution’s education curricula. to Submit Response: Responses this RFI be accepted through September 1, 2019. Responses this RFI must submitted electronically via email to: paineducation@nih.gov Responses this RFI voluntary. not include any proprietary, classified, confidential, trade secret, sensitive information your response. responses be reviewed NIH staff, individual feedback not provided any responder. Government use information submitted response this RFI its discretion. Government reserves right use any submitted information public NIH websites, reports, summaries the state the science, any possible resultant solicitation(s), grant(s), cooperative agreement(s), in development future funding opportunity announcements. RFI for information planning purposes only shall be construed a solicitation, grant, cooperative agreement, as obligation the part the Federal Government, NIH, individual NIH Institutes Centers provide support any ideas identified response it. Government not pay the preparation any information submitted for Government’s of such information. basis claims against U.S. Government shall arise because a response this request information from Government’s of such information. NIH looks forward your input we hope you share RFI document your colleagues. Inquiries Please direct inquiries to: Shelley Su, PhD National Institute Drug Abuse Telephone: 301-402-3869 Email:paineducation@nih.gov

Notice Change Application Types Allowed RFA-NS-18-021 BRAIN Initiative: Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System UG3/UH3 Clinical Trial Required)" Notice Number: NOT-NS-19-072 Key Dates Release Date: June 28, 2019 Related Announcements RFA-NS-18-021 Issued National Institute Neurological Disorders Stroke NINDS) National Institute Deafness Other Communication Disorders NIDCD) Purpose purpose this notice to inform applicants revision applications be accepted response RFA-NS-18-021 BRAIN Initiative: Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System UG3/UH3 Clinical Trial Required)". Changes listed below bold italics). notice be effective the October 21, 2019 due date subsequent due dates. Currently Reads: Section II. Award Information Application Types Allowed? New Resubmission Modified Read: Section II. Award Information Application Types Allowed New Resubmission Revision other aspects this FOA remain unchanged.? Inquiries Please direct inquiries to: Nick Langhals, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: nick.langhals@nih.gov

Notice Change Application Types Allowed RFA-NS-18-022 BRAIN Initiative: Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System U44 Clinical Trial Required)" Notice Number: NOT-NS-19-073 Key Dates Release Date: June 28, 2019 Related Announcements RFA-NS-18-022 Issued National Institute Neurological Disorders Stroke NINDS) National Institute Deafness Other Communication Disorders NIDCD) Purpose purpose this notice to inform applicants revision applications be accepted response RFA-NS-18-022 BRAIN Initiative: Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System U44 Clinical Trial Required)". Changes listed below bold italics). notice be effective the October 21, 2019 due date subsequent due dates. Currently Reads: Section II. Award Information Application Types Allowed? New Resubmission Modified Read: Section II. Award Information Application Types Allowed New Resubmission Revision other aspects this FOA remain unchanged.? Inquiries Please direct inquiries to: Nick Langhals, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: nick.langhals@nih.gov

Notice Change Application Types Allowed RFA-NS-18-023 BRAIN Initiative: Clinical Studies Advance Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System UH3 Clinical Trial Required)" Notice Number: NOT-NS-19-074 Key Dates Release Date: June 28, 2019 Related Announcements RFA-NS-18-023 Issued National Institute Neurological Disorders Stroke NINDS)National Institute Deafness Other Communication Disorders NIDCD) Purpose purpose this notice to inform applicants revision applications be accepted response RFA-NS-18-023 BRAIN Initiative: Clinical Studies Advance Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System UH3 Clinical Trial Required)". Changes listed below bold italics). notice be effective the October 21, 2019 due date subsequent due dates. Currently Reads: Section II. Award Information Application Types Allowed? New Resubmission Modified Read: Section II. Award Information Application Types Allowed New Resubmission Revision other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Nick Langhals, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: nick.langhals@nih.gov

Notice Correction Application Submission Information PAR-18-543 CREATE Bio Development Track: Nonclinical Early-Phase Clinical Development Biologics U44 Clinical Trial Optional)" Notice Number: NOT-NS-19-070 Key Dates Release Date: June 19, 2019 Related Announcements PAR-18-543 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform potential applicants a correction the Application Submission Information for PAR-18-543 , CREATE Bio Development Track: Nonclinical Early-Phase Clinical Development Biologics U44 Clinical Trial Optional) ". Application Submission Information Section been modified include information was erroneously omitted. notice be effective the July 18, 2019 receipt date subsequent due dates. correction applies the sentence below written in bold italics) the Page Limitations Section IV.2. Content Form Application Submission. page limitations described the SF424 R&R) SBIR/STTR Application Guide the Table Page Limits must followed. sentence corrected read: page limitations described the SF424 R&R) SBIR/STTR Application Guide the Table Page Limits must followed. this specific FOA, Research Strategy section limited 30 pages. other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov

Notice Allow Requests Budget Increases NINDS Research Program Award R35) Notice Number: NOT-NS-19-058 Key Dates Release Date: June 12, 2019 Related Announcements RFA-NS-19-037 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform current future recipients the NINDS R35 Research Program Award RPA) the opportunity request budget increase based exceptional circumstances the year five 5) administrative review. RPA provides long-term support Principal Investigators PIs) consolidating NINDS research support a single funding vehicle up eight years a fixed level is generally commensurate the PI’s funding over prior four years. greater funding stability provides recipients increased freedom flexibility, allowing to more adventurous their research, take greater risks, embark upon research breaks new ground, undertake research projects require longer timeframe, and/or extend previous discoveries new directions. Under exceptional circumstances, will consider requests budget increases the year five administrative review capitalize groundbreaking scientific findings. Although RPA budget exceed 750K direct costs DC) per year, requests increases 50K DC increments, a maximum 150K DC, be considered discussed the NINDS Advisory Council. approved, increase extend the duration the award. evaluating proposed budget increase, factors NINDS consider include: 1) PI’s support including non-NIH non-Federal funding); 2) career stage the PI; 3) progress the research program during first four years the R35 award; 4) size the initial R35 award. PIs significant support generally receive budget increases. specific guidance be provided R35-funded investigators advance the Year 5 administrative review. Inquiries Please direct inquiries to: Anna Taylor, Ph.D. National Institute Neurological Disorders Stroke NINDS) / Division Extramural Activities DEA) Telephone: 301-827-3565 Email: Anna.Taylor@nih.gov

Notice Intent Publish Funding Opportunity Announcement NIH Blueprint Neuroscience Research Education Program Translational Devices R25) Notice Number: NOT-NS-19-068 Key Dates Release Date: June 12, 2019 Estimated Publication Date Funding Opportunity Announcement: August 16, 2019 First Estimated Application Due Date: December 16, 2019 Earliest Estimated Award Date: June 01, 2020 Earliest Estimated Start Date: July 01, 2020 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Dental Craniofacial Research NIDCR) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Nursing Research NINR) National Center Complementary Integrative Health NCCIH) applications this funding opportunity announcement should fall within mission the Institutes/Centers. following NIH Offices co-fund applications assigned those Institutes/Centers. Office Behavioral Social Sciences Research OBSSR) Purpose National Institute Neurological Disorders Stroke NINDS), other NIH Institutes Centers the NIH Blueprint Neuroscience Research consortium, intends promote new initiative publishing Funding Opportunity Announcement FOA) solicit applications develop comprehensive set short courses draws lessons learned academia industry is aimed filling translational knowledge gap the academic investigator small business communities. courses should address unique challenges inherent developing translating novel devices diagnose treat nervous system disorders. Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects anticipation the FOA. FOA expected be published the summer 2019 an expected application due date the winter 2019. FOA utilize R25 activity code. Details the planned FOA provided below. Research Initiative Details Notice encourages investigators expertise insights successful development translation medical devices diagnose treat nervous system disorders begin consider applying this new FOA. Applicants be encouraged develop creative education activities focused 1) steps required successful device development translation eg, animal model selection, good laboratory practices, quality systems, regulatory activities, clinical trial design, etc.), 2) common technical strategic challenges, 3) providing resources mentors each stage the process. education activities be expected address broad audience, including post-doctoral fellows, independent academic researchers, small business entrepreneurs. Applications be expected describe critical aspects of a program plan including, not limited to, course details, location, personnel, educational environment/facilities, recruitment diversity strategies. should also address to incorporate responsible conduct research ethical considerations developing translating devices, course evaluation methods, dissemination plans make course materials widely available. Funding Information Estimated Total Funding 250,000 direct costs Expected Number Awards 1 Estimated Award Ceiling 250,000 direct costs Primary CFDA Numbers TBD Anticipated Eligible Organizations Public/State Controlled Institution Higher Education Private Institution Higher Education Nonprofit 501(c)(3) IRS Status than Institution Higher Education) Small Business For-Profit Organization than Small Business) State Government Indian/Native American Tribal Government Federally Recognized) County governments Independent school districts Public housing authorities/Indian housing authorities Indian/Native American Tribally Designated Organization Native American tribal organizations than Federally recognized tribal governments) U.S. Territory Possession Indian/Native American Tribal Government than Federally Recognized) Non-domestic non-U.S.) Entity Foreign Organization) Regional Organization Eligible Agencies the Federal Government Applications not being solicited this time. Inquiries Please direct inquiries to: Kari Ashmont, PhD National Institute Neurological Disorders Stroke NINDS) 301-496-1779 kari.ashmont@nih.gov

Notice Change Key Dates PAR-18-710 Career Transition Award NINDS Intramural Clinician-Scientists K22 Clinical Trial Required)" Notice Number: NOT-NS-19-066 Key Dates Release Date: June 6, 2019 Related Announcements PAR-18-710 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a change the Key Dates PAR-18-710 Career Transition Award NINDS Intramural Clinician-Scientists K22 Clinical Trial Required)" changes shown bold italics below). Funding Opportunity Announcement been modified add following New Application Due dates: October 12, 2019, February 12, 2020; June 12, 2020; October 12, 2020; February 12, 2021; June 12, 2021 and resubmission application due dates: November 12, 2019; March 12, 2020; July 12, 2020; November 12, 2020; March 12, 2021; July 12, 2021. Currently Reads: Part 1. Overview Key Dates: Application Due Date(s) Standard dates , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date July 13, 2019 Modified Read: Part 1. Overview Key Dates: Application Due Date(s) Standard dates , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date July 13, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@ninds.nih.gov

Notice Change Key Dates PAR-18-711 Career Transition Award NINDS Intramural Clinician-Scientists K22 Clinical Trial Allowed)" Notice Number: NOT-NS-19-067 Key Dates Release Date: June 6, 2019 Related Announcements PAR-18-711 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a change the Key Dates PAR-18-711 Career Transition Award NINDS Intramural Clinician-Scientists K22 Clinical Trial Allowed)" changes shown bold italics below). Funding Opportunity Announcement been modified add following New Application Due dates: October 12, 2019, February 12, 2020; June 12, 2020; October 12, 2020; February 12, 2021; June 12, 2021 and resubmission application due dates: November 12, 2019; March 12, 2020; July 12, 2020; November 12, 2020; March 12, 2021; July 12, 2021. Currently Reads: Part 1. Overview Key Dates: Application Due Date(s) Standard dates , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date July 13, 2019 Modified Read: Part 1. Overview Key Dates: Application Due Date(s) Standard dates , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date July 13, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@ninds.nih.gov

Request Information RFI): NINDS Soliciting Input Enhancing Neuroscience Research Institutions Emerging Neuroscience Programs Notice Number: NOT-NS-19-059 Key Dates Release Date: 17, 2019 Response Date: June 17, 2019 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) Purpose recent years, explosion advanced neurotechnology led exciting new discoveries advances neuroscience. has also led a widening technology gap between leading neuroscience institutions, institutions emerging neuroscience programs. advances sophisticated approaches, technologies instrumentation neuroscience research increased need cost-effective access these resources through shared core facilities enhance quality science. purpose this Request Information RFI) to seek input the neuroscience community help define research resource needs institutions where growth neuroscience research programs limited the lack access specialized expertise, instruments services. Information Requested NINDS soliciting input researchers, institutional leadership, science administrators, research professional organizations, other interested members the neuroscience community, improving access research resources technology, instruments approaches) institutions emerging neuroscience programs. your response please indicate role the neuroscience community. you submitting response a researcher administrator/leader a research institution, please provide estimate the number program directors/principle investigators PI/PDs) engaged primarily neuroscience research your institution. you responding behalf a professional organization, please indicate name your organization. Please provide perspective the importance any all these research resources, their role fostering growth development emerging neuroscience research programs: Shared resource facility staff specialized expertise Basic shared resource facilities e.g., microscopy, animal behavior, etc.) Shared resource facilities advanced technologies e.g., Cryo EM, Light Sheet Microscopy, etc.) Training researchers specialized approaches techniques offered shared resource facilities please specify) to Submit Response Responses this RFI must submitted electronically. Responses be accepted through 06/17/2019. Respondents advised the Government under obligation acknowledge receipt the information received provide feedback respondents respect any information submitted. Responses be shared publicly an NIH website. Please not include any personally identifiable other information you not wish make public. proprietary, classified, confidential, sensitive information should included your response. request for information planning purposes only should be construed a solicitation as obligation the part the United States Government. NIH not any awards based responses this RFI pay the preparation any information submitted for Government's of such information. Inquiries Please direct inquiries to: Timothy LaVaute, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1447 Email: research.resources@ninds.nih.gov